Clinical Trial Update: Adalimumab Plus Methotrexate for the Treatment of Pediatric Uveitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating adalimumab plus methotrexate for pediatric uveitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveitis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Uveitis | Phase 2 | Status: UNKNOWN